ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 6.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2025-03-14
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-06-30 was 0.00 shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-03-31 was 6.00K shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 6.00K shares, a 95.52% decline from fiscal 2023.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 134.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|
| 2024-12-31 | 6.00K shares 10-K · filed 2025-03-14 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 6.00K shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 6.00K shares 10-Q · filed 2024-05-15 | ||
| 2023-12-31 | 134.00K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |